Sign in
TRGNF Stock Price, Chart, Stats & News
Transgene S.A.
Save
Transgene S.A. (TRGNF) does not currently pay a dividend.
115.36M
Market cap
–
Current P/E
–
Forward P/E
TRGNF chart
About
Health care
Sector
Biotechnology
Industry
Transgene S. A. is a biotechnology company dedicated to the creation and advancement of therapeutic vaccines and oncolytic viruses. Its core mission is to develop innovative treatments for both cancer and various infectious diseases.
Similar securities
Based on sector and market capitalization
Report issue